Coeptis Therapeutics News

D: Filing D

Jun 27 15:08 ET

Coeptis Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.96%),Steven Boyd(9.96%)

Feb 14 15:38 ET

Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cogley Brian

Jan 17 00:00 ET

Coeptis Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Cogley Brian

Jan 17 00:00 ET

Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DeSilva Tara

Jan 16 00:00 ET

Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yerace Daniel Alexander

Jan 9 00:00 ET

Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Salkind Gene

Jan 9 00:00 ET

Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mehalick David

Jan 9 00:00 ET

Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Cochran Christopher P.

Jan 9 00:00 ET

Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mehalick David

Dec 11, 2023 16:01 ET

Coeptis Therapeutics | D: Filing D

Nov 3, 2023 14:03 ET

Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Calise Chris

Aug 31, 2023 16:01 ET

Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Salkind Gene

Aug 30, 2023 15:15 ET

Coeptis Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Harraden Circle Investors, LP(0.0%),Harraden Circle Investors GP, LP(0.0%), etc.

Feb 14, 2023 19:09 ET

Coeptis Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hudson Bay Capital Management LP(0%),Sander Gerber(0%)

Feb 6, 2023 16:25 ET

Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jan 31, 2023 11:09 ET

Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jan 31, 2023 11:05 ET

Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jan 31, 2023 11:03 ET

Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jan 31, 2023 10:59 ET

Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jan 31, 2023 10:55 ET